Navigation Links
Cantel Medical Corp. to Present at the Sidoti Emerging Growth Research Institutional Investor Forum
Date:11/5/2009

LITTLE FALLS, N.J., Nov. 5 /PRNewswire-FirstCall/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Andrew A. Krakauer, President & CEO, will be presenting at the Sidoti & Company, LLC Emerging Growth Research Institutional Investor Forum. The formal presentation is scheduled for 9:05 AM ET on Friday, November 20, 2009 at the Grand Hyatt New York, with a Q & A session immediately following the presentation. In addition, Mr. Krakauer and Seth R. Segel, Executive Vice President, will be available for separate one-on-one meetings during the day. The presentation will be available on the Investor Relations section of the Company's website: www.cantelmedical.com.

Cantel Medical Corp. (NYSE: CMN) is a leading provider of infection prevention and control products in the healthcare market. Our products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens. For more information, please visit http://www.cantelmedical.com.

SOURCE Cantel Medical Corp.


'/>"/>
SOURCE Cantel Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cantel Medical Corp.s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products
2. Cantel Medical Corp. To Hold Conference Call To Discuss Fourth Quarter and Fiscal 2009 Results
3. Cantel Medicals Crosstex Subsidiary Launches New Specially Treated Face Mask Effective Against H1N1 Influenza
4. Cantel Medical Named to the Forbes 2009 List of the 200 Best Small Companies in America
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. Globus Medical Raises $110 Million in Series E Financing Round
9. Quark Pharmaceuticals Appoints New Chief Medical Officer
10. Boston University Biomedical Engineers Find Chink in Bacterias Armor
11. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ewswire/--AccordingtoMillenniumResearchGroup(MRG),...gence,thenearly$3billionUSmarketfortraumafixationd...earsdespitetherecenteconomicslowdown.MRG,s USMarke...willremainhighlydynamicoverthenextfiveyears,withco...underservedsegmentsofthetraumafixationmarket,fueli...
(Date:11/25/2009)...OHANNESBURG,November25/PRNewswire/--,iThembaPharma...dtoday,thattheyhavesignedacollaborativeagreementto...,sworldclasscomputationalchemistryandleaddiscovery...ntoprovidemedicinaland,syntheticchemistrysupportto...tnetwork.iThembaPharmaceuticalsandPyxisDiscovery,a...
(Date:11/24/2009)...ewswire-FirstCall/--Endologix,Inc.(Nasdaq: ELGX ),...orders,announcedtodaythatithasfiledamotiontostay,o...lawsuitbroughtagainstitinOctober2009byCook,Inc.The...anapolis,Indiana. ,, Endologixhasrequestedthatt...rademarkOffice(USPTO)conductsproceedingstore-exami...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH Receptor Targeted Cytotoxic Conjugate AEZS 108 in Endometrial Cancer 14959 1AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH Receptor Targeted Cytotoxic Conjugate AEZS 108 in Endometrial Cancer 14959 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH Receptor Targeted Cytotoxic Conjugate AEZS 108 in Endometrial Cancer 14959 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH Receptor Targeted Cytotoxic Conjugate AEZS 108 in Endometrial Cancer 14959 4Genomic Health to Present at Piper Jaffray Health Care Conference 14955 1Genomic Health to Present at Piper Jaffray Health Care Conference 14955 2Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 6501 1Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 6501 2
...5 Million Interferon-Beta-CTP Development Program ...a Special Grant From the Israeli Office of the ...NA, Israel, Aug. 5 Modigene Inc. (OTC,Bulletin Bo...&D subsidiary,has received approval for a special ...st ("OCS") in support of the company,s development...
...-Term Clinical Study Confirms Effectiveness of Aut...he results of a two-year,representative study of k...ly renowned journal "Osteoarthritis and Cartilage"...e therapy, in which,anti-inflammatory proteins obt...to the arthritic joint., Researchers at Heinrich ...
Other Medicine Technology:Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta 2Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta 3Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta 4Orthokine Treatment is Effective for Knee Arthritis, Even After Two Years 2
(Date:11/25/2009)...rological symptoms, study finds , , WED...ide effects are among the potential problems faced...ere treated with cisplatin-based chemotherapy, a n...Norwegian men treated for unilateral testicular ca...ow-up survey conducted from 1998 to 2002. , The...
(Date:11/25/2009)...ire/-- MISSIONSkincare ®isproudtosupportGNC,s...GNC,sannualSt.Jude ThanksandGiving campaign,$1from...PER-C(TM)LipBalm willbedonatedtoSt.Jude.Additional...donationatcheckoutatoneoftheir5,000+retaillocation....Judeduringtheir2009 ThanksandGiving campaign. ,...
(Date:11/25/2009)...wnforthe4thStraightYear ,, WASHINGTON,Nov.25/...-Georgia(LCA-GA)issuedthe 4thAnnualReportCardonLun...deagainstthislethaldiseaseinthestateofGeorgia.LCA-...nalorganizationdedicatedexclusivelytopatientsuppor...er. ,, (Logo: http://www.newscom.com/cgi-bin/pr...
(Date:11/25/2009)...tal cancer also can reverse a rare stomach disorde...the disease, researchers at Vanderbilt University ...ase causes thickening of the stomach lining, sever...anemia and swelling in the feet and ankles due to ...astric cancer. Previously, the only effective trea...
(Date:11/25/2009)...e skin kill tumor cells, study finds , ,...accine delivered in a fingernail-size implant elim...s. , The method uses polymer disks, 8.5 millime...fic antigens and implanted under the skin to repro...rd University scientists who developed the implant...
Breaking Medicine News(10 mins):Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2
...pulmonary syndrome (HPS) develops when an arterial...ary vascular dilatations that are often associated... of patients with liver cirrhosis undergoing evalu...ly in those with decompensated liver disease. , ...
... lead to better smoking-cessation aids , WEDNESDAY...e brain show increased activation in smokers who a...sylvania study. , The finding may boost understan...n imaging studies showing how subjects respond to ...
.... 18 Kids want help from adults,as they face a da...ectures,only scare them away. ethiKids, inc. intro...ns open during the formative pre-teen years., On ...nges related to values and skills development. Its...
...nal Association joins LaSalle as a lender under th... SANTA ANA, Calif., Dec. 18 Grubb & Ellis,Healthc...ecured revolving,line of credit with LaSalle Bank ...ion to $80,million. The line of credit is for a te...
...ts Home Front Needs of Families with Deployed Serv...FT. RICHARDSON, Alaska, Dec. 18 TriWest Healthcar...onal Guard Officer,s,Auxiliary - Friends of the Gu...president for the Alaska area at TriWest,will pres...
...nn., Dec. 18 Cumberland Pharmaceuticals is,please...ives., David L. Lowrance has been promoted to Vic...ole, he is responsible for overseeing the,company,...oining Cumberland in 2003 as Director of Finance,a...
Other Medicine News:Health News:Who is the arch-criminal in the development of hepatopulmonary syndrome? 2Health News:Smokers' Brain Centers Activate During Nicotine Cravings 2Health News:ethiKids, inc. Launches Website and Products to Address Declining Ethics in Children 2Health News:Grubb & Ellis Healthcare REIT Increases Line of Credit With LaSalle Bank to $80 Million 2Health News:Grubb & Ellis Healthcare REIT Increases Line of Credit With LaSalle Bank to $80 Million 3Health News:TriWest Contributes $12,000 to Alaska National Guard Fund 2Health News:Cumberland Pharmaceuticals Announces Appointments 2
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
Medicine Products: